Search | IOVS | ARVO Journals

Access Provided By:
MIT Libraries

Forgot password?

Create an Account

View

Showing 1 – 12 of 12

SORT: Best Match Most Recent Oldest

VIEW: Basic | Expanded

ARVO Annual Meeting Abstract September 2016

Clinical features and long-term progression of reticular pseudodrusen in age-related macular degeneration: Findings from a multi-center cohort

Joao Gil; João Pedro Marques; Ruth E Hogg; Chiara Rosina; Maria Luz Cachulo; Ana Rita Santos; Giovanni Staurenghi; Usha Chakravarthy; Rufino Martins Silva

Invest. Ophthalmol. Vis. Sci.. 2016; 57(12):4963.

ARVO Annual Meeting Abstract June 2013

Drusen Detection on Multimodal Imaging- Early Markers Observational Study

Rufino Silva; Ruth Hogg; George Murphy; Giovanni Staurenghi; Chiara Rosina; Ana Rita Santos; Usha Chakravarthy

Invest. Ophthalmol. Vis. Sci.. 2013; 54(15):4149.

ARVO Annual Meeting Abstract June 2013

Relationship between Visual Function and Optical Coherence Tomography features in Early Age-related macular degeneration (AMD)-Early Markers Observational Study

Ruth Hogg; George Murphy; Giovanni Staurenghi; Chiara Rosina; Rufino Silva; Ana Rita Santos; Usha Chakravarthy; Early Markers Observational Study.

Invest. Ophthalmol. Vis. Sci.. 2013; 54(15):5028.

ARVO Annual Meeting Abstract April 2010

Efficacy of Intravitreal Bevacizumab in Patients With Choroidal Neovascularization (CNV) in Angioid Streaks: Updates After Two Years Follow-Up

M. Oldani; C. Rosina; L. de Polo; M. V. Cigada; G. Staurenghi

Invest. Ophthalmol. Vis. Sci.. 2010; 51(13):2819.

ARVO Annual Meeting Abstract April 2010

Macular Atrophic Changes in Patients Treated With Bevacizumab for Myopic Choroidal Neovascularization

C. Rosina; A. Invernizzi; F. Bottoni; G. Staurenghi

Invest. Ophthalmol. Vis. Sci.. 2010; 51(13):2193.

ARVO Annual Meeting Abstract April 2010

Intravitreal Bevacizumab in the Treatment of Diabetic Macular Edema

P. A. Salvetti; L. Bonavia; C. Rosina; P. Sabella; M. Draghi; G. Staurenghi

Invest. Ophthalmol. Vis. Sci.. 2010; 51(13):4250.

ARVO Annual Meeting Abstract April 2009

Intravitreal Injection of Bevacizumab in Subfoveal Choroidal Neovascularization Due to Pathological Myopia: Updates Findings After 2 Years Follow Up

C. Rosina; L. Bertazzi; F. Bottoni; M. Cigada; G. Staurenghi

Invest. Ophthalmol. Vis. Sci.. 2009; 50(13):2280.

ARVO Annual Meeting Abstract May 2008

Blood Flow Modification in Feeder Vessels After Intravitreal Injection of Bevacizumab (Avastin)

G. Levi; T. Holmes; A. Invernizzi; C. Veronese; C. Rosina; E. Hermesmeyer; G. Staurenghi

Invest. Ophthalmol. Vis. Sci.. 2008; 49(13):321.

ARVO Annual Meeting Abstract May 2008

Intravitreal Pegaptanib Sodium for Choroidal Neovascularization Secondary to Age-Related Macular Degeneration- A Pan-European Experience

S. Sivaprasad; A. Saeed; S. Beatty; J. L. Olea; S. Grisanti; C. Rosina; G. Staurenghi; P. Hykin

Invest. Ophthalmol. Vis. Sci.. 2008; 49(13):335.

ARVO Annual Meeting Abstract May 2008

Intravitreal Injection of Bevacizumab in Subfoveal Choroidal Neovascularization Due to Pathological Myopia

C. Rosina; L. Bertazzi; F. Bottoni; G. Levi; M. Cigada; G. Staurenghi

Invest. Ophthalmol. Vis. Sci.. 2008; 49(13):3456.

ARVO Annual Meeting Abstract May 2007

Efficacy of Intravitreal Bevacizumab in Patients With Choroidal Neovascularization (CNV) in Angiod Streaks

C. Rosina; F. Viola; P. Avanza; G. Staurenghi

Invest. Ophthalmol. Vis. Sci.. 2007; 48(13):279.

ARVO Annual Meeting Abstract May 2007

The Length of the New Vessels Regression in Proliferative Diabetic Retinopathy After Intravitreal Bevacizumab

L. Bonavia; S. De Angelis; C. Rosina; G. Staurenghi

Invest. Ophthalmol. Vis. Sci.. 2007; 48(13):282.

Advertisement